Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Taliban
al Qaeda
Ayman al-Zawahiri
Joe Biden
United States of America
National Aeronautics and Space Administration
Monkeypox
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study
World

Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study

Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study
Written by Shalini Ojha
Mar 30, 2021, 11:07 am 2 min read
Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study

The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters. A study by the US Centers for Disease Control and Prevention (CDC) found that the vaccines worked two weeks or more after the first shot.

Findings
After both doses, risk of infection fell by 90%

Nearly 4,000 people were evaluated for this study and the real-world data painted a pleasant picture. After the first shot of the two-dose vaccines, the risk of infection reduced by 80%. It fell by 90% two weeks after the course was completed. "This study shows that our national vaccination efforts are working," CDC Director Rochelle Walensky's statement read.

Time
Volunteers were studied from mid-December to mid-March

The participants were observed between mid-December and mid-March, regardless of their symptoms. The CDC monitored their health via medical reports. They were asked to get tested on a weekly basis. More than 62% of the volunteers had completed the two-dose course while more than 12% had received just the first dose of either Pfizer's vaccine or the one developed by Moderna.

Details
Three people, who completed course, tested coronavirus positive

Out of 2,961 vaccinated people (they had received at least one dose) and the 989 unvaccinated volunteers, 205 people tested coronavirus positive after RT-PCR tests. Of the positive people, 161 had not been administered the vaccine; eight were partially protected, and three contracted the infection after getting both the doses. Two people had to be hospitalized and no one died.

Importance
Findings underscore the importance of getting both doses, said Walensky

Though these findings are in line with the results of clinical trials, such experiments are important to show the efficacy of vaccines in the real world. "These findings also underscore the importance of getting both of the recommended doses of the vaccine in order to get the greatest level of protection against COVID-19, especially as our concerns about variants escalate," Walensky said, reports CNN.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shalini Ojha
Shalini Ojha
Twitter
A mathematics graduate, I handle the national desk. Always looking for items to read, I started off as an entertainment beat writer and made the switch three years into my career. My talents include breaking news and being on top of trending topics.
Latest
Pfizer
Coronavirus
Moderna Inc
Latest
Netflix's latest series 'The Sandman' is unmissable. Here's why
Netflix's latest series 'The Sandman' is unmissable. Here's why Entertainment
Teclast P30 Air, with MediaTek chipset and Android 12, launched
Teclast P30 Air, with MediaTek chipset and Android 12, launched Technology
2023 Ford Explorer breaks cover in China: Check design, features
2023 Ford Explorer breaks cover in China: Check design, features Auto
All you need to know about 'Jhalak Dikhhla Jaa S10'
All you need to know about 'Jhalak Dikhhla Jaa S10' Entertainment
TECNO CAMON 19 Pro 5G's India launch on August 10
TECNO CAMON 19 Pro 5G's India launch on August 10 Technology
Pfizer
Biden tests positive for COVID-19; rare case of 'rebound positivity'
Biden tests positive for COVID-19; rare case of 'rebound positivity' World
New Omicron sub-variants can trigger new COVID-19 wave: Study
New Omicron sub-variants can trigger new COVID-19 wave: Study World
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine World
'Cautious optimism' after initial Omicron studies; here's what we know
'Cautious optimism' after initial Omicron studies; here's what we know Technology
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
Moderna Inc
Moderna COVID-19 vaccine produces lasting immune response: Study
Moderna COVID-19 vaccine produces lasting immune response: Study Technology
Japan suspends 1.63mn Moderna vaccine doses after contamination found
Japan suspends 1.63mn Moderna vaccine doses after contamination found World
No sign of Pfizer, Moderna vaccines in breast milk: Study
No sign of Pfizer, Moderna vaccines in breast milk: Study Technology
India offered 7.5mn doses of Moderna vaccine under COVAX program
India offered 7.5mn doses of Moderna vaccine under COVAX program India
Moderna vaccine arriving in India in 2-3 days: Report
Moderna vaccine arriving in India in 2-3 days: Report India
More News
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022